Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Namenda in Adult ADHD
NCT00586573Phase 4Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Mar 2007
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of memantine in attention deficit hyperactivity disorder (ADHD), sponsored by Massachusetts General Hospital. Started Mar 2007; status: completed.
02
Drugs
memantine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00586573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00586573.